Bio-FD&C Co. Ltd.
BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soot… Read more
Market Cap & Net Worth: Bio-FD&C Co. Ltd. (251120)
Bio-FD&C Co. Ltd. (KQ:251120) has a market capitalization of $80.85 Million (₩118.38 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #21415 globally and #1014 in its home market, demonstrating a 3.50% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bio-FD&C Co. Ltd.'s stock price ₩13880.00 by its total outstanding shares 8528949 (8.53 Million).
Bio-FD&C Co. Ltd. Market Cap History: 2022 to 2026
Bio-FD&C Co. Ltd.'s market capitalization history from 2022 to 2026. Data shows change from $99.02 Million to $80.85 Million (-10.90% CAGR).
Index Memberships
Bio-FD&C Co. Ltd. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.03% | #463 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.03% | #463 of 1384 |
Weight: Bio-FD&C Co. Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Bio-FD&C Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bio-FD&C Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Bio-FD&C Co. Ltd.'s market cap is 0.01 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.02x
Bio-FD&C Co. Ltd.'s market cap is 0.02 times its annual earnings
0.11x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $99.02 Million | $15.86 Billion | $4.34 Billion | 0.01x | 0.02x |
| 2023 | $82.25 Million | $15.59 Billion | $5.59 Billion | 0.01x | 0.01x |
| 2024 | $80.50 Million | $16.07 Billion | $4.50 Billion | 0.01x | 0.02x |
Competitor Companies of 251120 by Market Capitalization
Companies near Bio-FD&C Co. Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Bio-FD&C Co. Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Bio-FD&C Co. Ltd. Historical Marketcap From 2022 to 2026
Between 2022 and today, Bio-FD&C Co. Ltd.'s market cap moved from $99.02 Million to $ 80.85 Million, with a yearly change of -10.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩80.85 Million | -12.15% |
| 2025 | ₩92.03 Million | +14.33% |
| 2024 | ₩80.50 Million | -2.12% |
| 2023 | ₩82.25 Million | -16.94% |
| 2022 | ₩99.02 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bio-FD&C Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $80.85 Million USD |
| MoneyControl | $80.85 Million USD |
| MarketWatch | $80.85 Million USD |
| marketcap.company | $80.85 Million USD |
| Reuters | $80.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.